Raul R. Rodriguez
CEO, President at Rigel Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Rigel Pharmaceuticals Inc., 3 years.
Rigel Pharmaceuticals Inc.
Director · CEO, President
Chief executive roles
Rigel Pharmaceuticals Inc.
· CEO, President
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Rigel Pharmaceuticals Inc. | Shares withheld for tax | −2,424 | $29.86 | $72,381 |
| Feb 17, 2026 | Rigel Pharmaceuticals Inc. | Grant or award | +53,915 | — | — |
| Feb 10, 2026 | Rigel Pharmaceuticals Inc. | Shares withheld for tax | −7,607 | $34.62 | $263,354 |
| Feb 2, 2026 | Rigel Pharmaceuticals Inc. | Shares withheld for tax | −14,110 | $36.01 | $508,101 |
| Jan 26, 2026 | Rigel Pharmaceuticals Inc. | Option exercise | +40,000 | $27.40 | $1,096,000 |
| Jan 26, 2026 | Rigel Pharmaceuticals Inc. | Shares withheld for tax | −35,211 | $37.00 | $1,302,807 |
| Jan 26, 2026 | Rigel Pharmaceuticals Inc. | Option exercise | +40,000 | $27.40 | $1,096,000 |
| Jan 26, 2026 | Rigel Pharmaceuticals Inc. | Shares withheld for tax | −35,424 | $37.00 | $1,310,688 |
| Feb 5, 2025 | Rigel Pharmaceuticals Inc. | Open-market sale | −4,400 | $21.93 | $96,492 |
| Feb 4, 2025 | Rigel Pharmaceuticals Inc. | Open-market sale | −4,952 | $20.92 | $103,596 |
| Jan 29, 2025 | Rigel Pharmaceuticals Inc. | Grant or award | +42,300 | — | — |
| Jan 24, 2025 | Rigel Pharmaceuticals Inc. | Option exercise | +45,000 | $21.40 | $963,000 |
| Jan 24, 2025 | Rigel Pharmaceuticals Inc. | Shares withheld for tax | −44,078 | $22.17 | $977,209 |
| Jan 24, 2025 | Rigel Pharmaceuticals Inc. | Option exercise | +45,000 | $21.40 | $963,000 |
| Jan 24, 2025 | Rigel Pharmaceuticals Inc. | Shares withheld for tax | −44,078 | $22.17 | $977,209 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.